ALDH1A1 and breast cancer: Using these markers, it was found that BCSCs derived from basal-like breast cancers were more mesenchymal-like expressing CD24low/−CD44+, whereas luminal ER+ breast cancer subtypes contained an enriched population of ALDH1+ BCSCs and a diminished fraction of CD24low/−CD44+ BCSCs [25].